A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Levorphanol
Ajmaline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ajmaline.
Levorphanol
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Methotrimeprazine.
Levorphanol
Arformoterol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Arformoterol.
Levorphanol
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Lapatinib.
Levorphanol
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Lapatinib.
Levorphanol
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Lapatinib.
Levorphanol
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lapatinib.
Levorphanol
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Lapatinib.
Levorphanol
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lapatinib.
Levorphanol
Maprotiline
The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lapatinib.
Levorphanol
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Lapatinib.
Levorphanol
Terbutaline
The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Lapatinib.
Levorphanol
Dabigatran etexilate
The serum concentration of Dabigatran etexilate can be increased when it is combined with Lapatinib.
Levorphanol
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Lapatinib.
Levorphanol
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Lapatinib.
Levorphanol
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Lapatinib.
Levorphanol
Remdesivir
The serum concentration of Remdesivir can be increased when it is combined with Lapatinib.
Levorphanol
Fostemsavir
The serum concentration of Fostemsavir can be increased when it is combined with Lapatinib.
Levorphanol
Belinostat
The serum concentration of Belinostat can be increased when it is combined with Lapatinib.
Levorphanol
Ripretinib
The serum concentration of Ripretinib can be increased when it is combined with Lapatinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3